# Hip studies don't support promises of new cartilage *What Hip Studies Show — Hip Regeneration Phoenix* > Hip regeneration Phoenix research on PRP, soreness, walking, and claims about new cartilage. Does research show that PRP helps sore hips? PRP is a concentrated part of blood drawn from you. In some hip studies, people said their soreness eased. Yet all the hip research together hasn't shown clear relief. The studies haven't shown that PRP rebuilds hip cartilage. ## Feeling better doesn't prove cartilage grew Soreness may ease for several reasons. Time, rest, hope, and shorter walks can all help. That's why researchers compare groups receiving different care. Some hip studies found less pain after PRP. People given a plain saltwater procedure improved too. That procedure copied the clinic visit but didn't use PRP. Across the research, PRP hasn't clearly helped pain, walking, or stairs more. That doesn't mean nobody feels relief. It means researchers can't credit PRP with certainty. Your own result can't be promised either. ## Knee results can't answer for your hip There are fewer hip studies than knee studies. Knees and hips move in different ways. A knee finding can't tell you what your hip will do. Some knee research found thicker cartilage without less pain. Other knee research found no pain relief or cartilage change. Neither finding proves what happens in a hip. Ask whether the people had sore hips. Then ask what changed for them. Did they hurt less or walk farther? A lower pain rating doesn't mean cartilage grew. ## Write down what you can do before treatment Choose one daily task before any care begins. You might put on a shoe. You might walk through a store. Write how far you get before stopping. Try the same task again later. Don't replace it with an easier one. Say plainly when nothing has changed. Start your notes at home. Record sleep, time on foot, stair use, and medicine. Bring them when you discuss more care. QC Kinetix can examine the sore hip and discuss regenerative treatments, clinic procedures using your blood or bone marrow. ## Sources 1. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo. Gazendam A, et al. — [Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.](https://pubmed.ncbi.nlm.nih.gov/32829298/). *British Journal of Sports Medicine*, 2021. DOI: 10.1136/bjsports-2020-102179. 2. The AAOS evidence-based clinical practice guideline on Management of Osteoarthritis of the Hip states verbatim: STRONG evidence supports intra-articular corticosteroids to improve function and reduce pain in the SHORT TERM; STRONG evidence does NOT support intra-articular hyaluronic acid, because it does not perform better than placebo for function, stiffness and pain; STRONG evidence supports physical therapy for mild to moderate symptoms; STRONG evidence supports NSAIDs for short-term pain and function; and MODERATE evidence does not support glucosamine sulfate. American Academy of Orthopaedic Surgeons — [Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline.](https://www.aaos.org/oahcpg). *AAOS*, 2017. 3. A systematic review of five randomized trials of intra-articular PRP for hip OA (43-111 patients each) reported significant pain reduction and functional improvement in every included study with no major adverse events, but methodological quality ranged from low to high risk of bias and PRP preparation methods differed between studies - so this positive summary rests on a small and heterogeneous base and does not override the placebo-controlled network meta-analysis. Almutairi AN, Alazzeh MS — [Efficacy and Safety of Platelet-Rich Plasma (PRP) Intra-articular Injections in Hip Osteoarthritis: A Systematic Review of Randomized Clinical Trials.](https://pubmed.ncbi.nlm.nih.gov/39569300/). *Cureus*, 2024. DOI: 10.7759/cureus.72057. 4. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products. US Food and Drug Administration, Center for Biologics Evaluation and Research — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA*, 2020. 5. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 6. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred. Mautner K, et al. — [Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.](https://pubmed.ncbi.nlm.nih.gov/37919438/). *Nature medicine*, 2023. DOI: 10.1038/s41591-023-02632-w. 7. A GRADE-rated systematic review and meta-analysis of 16 randomized trials (807 participants) found that MSC therapy for chronic knee OA pain PROBABLY RESULTS IN LITTLE TO NO DIFFERENCE in pain relief at 3-6 months (WMD -0.74 cm on a 10 cm VAS against a minimally important difference of 1.5 cm) or physical functioning (WMD 2.23 on the SF-36 100-point subscale against a 10-point MID), both moderate certainty; at 12 months pain was again probably little-to-no-different (WMD -0.73 cm). The measured effect is real but sits BELOW the threshold at which a patient would notice it. Sadeghirad B, et al. — [Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials.](https://pubmed.ncbi.nlm.nih.gov/38777213/). *Osteoarthritis and cartilage*, 2024. DOI: 10.1016/j.joca.2024.04.021. 8. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit. Awad G, et al. — [Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/41863718/). *Clinical rheumatology*, 2026. DOI: 10.1007/s10067-026-08042-w. ## A clinic visit starts with an exam of your hip Your first QC Kinetix consultation costs nothing. Clinic staff examine you and discuss regenerative treatments made from your blood or bone marrow, the soft center within a bone. Book a free consultation: --- Find the cause. Ease the soreness. Direct help with hip soreness, home care, Phoenix visits, and choices that don't involve surgery. Plain guidance on hip soreness, home care, and preparing for a clinic visit. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including Banner Estrella, Scottsdale, Peoria and Chandler, and it benefits when readers book with those clinics. © 2026 The Hip Signal. General education, not medical advice or a diagnosis; discuss your own hip with a qualified clinician.